Rieke H, Larsen R, Stephan H, Sonntag H, van der Linde H
Zentrum Anästhesiologie, Universität Göttingen.
Anasth Intensivther Notfallmed. 1988 Dec;23(6):297-302.
The cardioprotective efficacy of preoperatively maintained long-term oral nifedipine application to 21 patients undergoing coronary artery bypass grafting (CABG) was investigated during fentanyl-N2O-anaesthesia. Two groups were defined at random; one group of patients receiving their normal morning doses together with the premedication, the other, who received the last nifedipine medication in the evening before surgery. Measurements where performed: 1. before induction of anaesthesia (reference value), 2. after induction, 3. at skin incision, 4. during sternotomy. There were no significant differences of hemodynamic parameters between the two groups. The hemodynamic parameters heart rate (HR), mean arterial pressure (MAP), cardiac index (CI), and coronary perfusion pressure (CPP) decreased after induction in accordance with the plasma-concentrations of epinephrine and norepinephrine in both groups and increased again during sternotomy with HR and CI remaining below and MAP and CPP rising above the reference value. The nifedipine-plasma-concentrations were significantly higher in the group with the morning dose and just within the minimal therapeutic range before and after induction of anaesthesia. But during skin incision and sternotomy the plasma levels fell below 10 ng/ml, i.e. below the therapeutic level. The incidence of myocardial lactate extraction values greater than 10% was highest immediately after induction of anaesthesia and lowest during sternotomy with one patient in both groups exhibiting negative lactate extraction as a symptom of myocardial ischemia. The results suggest that the preoperatively maintained oral nifedipine medication of 10-20 mg p.o. was not able to provide sufficiently high nifedipine-plasma-levels during sternotomy nor to improve the hemodynamic state in patients with CABG.(ABSTRACT TRUNCATED AT 250 WORDS)
在芬太尼 - 氧化亚氮麻醉期间,研究了术前长期口服硝苯地平对21例接受冠状动脉搭桥术(CABG)患者的心脏保护效果。随机分为两组;一组患者在术前用药时服用正常的早晨剂量,另一组在手术前一晚服用最后一剂硝苯地平。进行了以下测量:1. 麻醉诱导前(参考值),2. 诱导后,3. 皮肤切开时,4. 胸骨切开术期间。两组之间的血流动力学参数无显著差异。两组的心率(HR)、平均动脉压(MAP)、心脏指数(CI)和冠状动脉灌注压(CPP)在诱导后均随肾上腺素和去甲肾上腺素的血浆浓度下降,在胸骨切开术期间再次升高,HR和CI仍低于参考值,MAP和CPP高于参考值。早晨服药组的硝苯地平血浆浓度显著更高,且在麻醉诱导前后刚好处于最小治疗范围内。但在皮肤切开和胸骨切开术期间,血浆水平降至10 ng/ml以下,即低于治疗水平。心肌乳酸摄取值大于10%的发生率在麻醉诱导后立即最高,在胸骨切开术期间最低,两组均有1例患者表现出乳酸摄取为负,这是心肌缺血的症状。结果表明,术前维持口服10 - 20 mg硝苯地平不能在胸骨切开术期间提供足够高的硝苯地平血浆水平,也不能改善CABG患者的血流动力学状态。(摘要截短至250字)